Provided by Tiger Trade Technology Pte. Ltd.

Krystal Biotech Inc.

346.58
+9.562.84%
Post-market: 346.580.00000.00%19:30 EDT
Volume:407.81K
Turnover:140.84M
Market Cap:10.26B
PE:43.51
High:348.03
Open:337.44
Low:335.72
Close:337.02
52wk High:382.54
52wk Low:136.73
Shares:29.60M
Float Shares:23.54M
Volume Ratio:2.19
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.97
EPS(LYR):6.84
ROE:20.12%
ROA:9.37%
PB:7.55
PE(LYR):50.67

Loading ...

Krystal Biotech (KRYS) Rallies On Pipeline Hopes But Is The Valuation Already Priced In

Simply Wall St.
·
Yesterday

Should Surging Vyjuvek-Driven Earnings Reshape How Krystal Biotech (KRYS) Investors View Its Risk Profile?

Simply Wall St.
·
Aug 16

Krystal Biotech Director Dino A. Rossi Disposes of USD 8.17 Million in Common Shares

Reuters
·
Aug 15

Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says

MT Newswires Live
·
Aug 14

Krystal Biotech (KRYS) Has a New Rating from RBC Capital

TIPRANKS
·
Aug 14

Krystal Biotech, Inc. : RBC Initiates Coverage with Outperform Rating; Target Price $400

THOMSON REUTERS
·
Aug 14

Krystal Biotech (KRYS) Earnings And Pipeline Progress Put Valuation Back In Focus

Simply Wall St.
·
Aug 13

Arcutis Q2 Revenue Rises on Demand for Zoryve, Lifts 2026 Sales Outlook

Reuters
·
Aug 06

United Therapeutics Q2 Revenue Misses Estimates on Ebulized Tyvaso Weakness

Reuters
·
Aug 05

Ultragenyx Q2 Revenue Rises 28% to Record High, Net Loss Narrows

Reuters
·
Aug 05

Movement Alert|Krystal Biotech Inc. Rises 5.04% in Regular Trading, Q2 Earnings Beat Drives Oversold Rebound

Market Focus
·
Aug 05

ClearPoint Neuro Q2 Revenue Rises 18% but Misses Estimates

Reuters
·
Aug 04

GeneDx Q2 Revenue Beats Analyst Estimates

Reuters
·
Aug 04

Krystal Biotech Down Nearly 12%, on Pace for Largest Percent Decrease Since August 2025

Dow Jones
·
Aug 04

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 04

Stock Track | Krystal Biotech Plummets 9.29% Intraday as Q2 Revenue Miss, Expense Guidance Fuel Sell-Off

Stock Track
·
Aug 03

Movement Alert|Krystal Biotech Inc. Falls 5.31% in Regular Trading, Q2 Revenue Misses Expectations Triggering Profit-Taking

Market Focus
·
Aug 03

Krystal Biotech Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 03

Design Therapeutics Q2 Net Loss Narrower than Expected

Reuters
·
Aug 03

Movement Alert|Krystal Biotech Inc. Falls 7.65% in Pre-Market Trading, Q2 Revenue Misses Market Expectations Despite EPS Beat

Market Focus
·
Aug 03